Complement Inhibitor and Enzyme/Protein Replacement Therapy - Index
Medications listed in the tables and non-FDA approved indications included in these retrospective criteria are not indicative of Texas Vendor Drug Program formulary coverage.
- Revision history:
- April 26, 2024
- April 2022
- March 2020
- March 2018
- March 2017
- April 2015
- March 2015
- Feb. 2013
- Dec. 2012 (initially developed)